Jenavalve Technology
Irvine, US · Delaware corporation · 2 known investors
Healthtech
Founders & leadership
RC
Raymond CohenDirector
EA
Erik AmbleDirector
JK
Jan KeltjensDirector
PB
Peter BarrettDirector
OL
Olivier LitzkaDirector
OX
Ouyang XiangyuDirector
PV
Patrick van BenedenDirector
VC
Victoria Carr-BrendelExecutive Officer, Director
HF
Hans-Reiner FigullaDirector
AK
Arnd KaltofenDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$100.4MraisedApr 2024 · 17 investors · Other Health CareRule 506(b)
▶$100.4MraisedApr 2024 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel DearenDirector
- Jan KeltjensDirector
- John KilcoyneExecutive Officer, Director
- Andrew HackDirector
- Jan PensaertDirector
- Keith DawkinsDirector
- Olivier LitzkaDirector
- Kenneth MacLeodDirector
- Offering amount
- $100.4M
- Amount sold
- $100.4M
- Sales commissions
- $525K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$66.5MraisedOct 2020 · 8 investors · Other Health CareRule 506(b)
▶$66.5MraisedOct 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew HackDirector
- Olivier LitzkaDirector
- Erik AmbleDirector
- Patrick van BenedenDirector
- Jose (Pepe) Calle GordoDirector
- Rudi MarienDirector
- Peter WulffExecutive Officer
- John KilcoyneExecutive Officer, Director
- Jan KeltjensDirector
- Keith DawkinsDirector
- Offering amount
- $66.5M
- Amount sold
- $66.5M
- Finders' fees
- $1.6M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.5MraisedJun 2019 · 10 investors · Other Health CareRule 506(b)
▶$14.5MraisedJun 2019 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John KilcoyneExecutive Officer, Director
- Jose Calle GordoDirector
- Peter WulffExecutive Officer
- Jan PensaertDirector
- Jan KeltjensDirector
- Keith DawkinsDirector
- Olivier LitzkaDirector
- Rudi MarienDirector
- Erik AmbleDirector
- Patrick van BenedenDirector
- Offering amount
- $14.5M
- Amount sold
- $14.5M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.3MraisedJul 2018 · 11 investors · Other TechnologyRule 506(b)
▶$14.3MraisedJul 2018 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Olivier LitzkaDirector
- Patrick van BenedenDirector
- Jan PensaertDirector
- Rudi MarienDirector
- Jose (Pepe) Calle GordoDirector
- Keith DawkinsDirector
- Victoria Carr-BrendelExecutive Officer
- Quan ZhouDirector
- Erik AmbleDirector
- Jan KeltjensDirector
- Offering amount
- $14.3M
- Amount sold
- $14.3M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.4MraisedAug 2017 · 14 investors · Other Health CareRule 506(b)
▶$9.4MraisedAug 2017 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ouyang XiangyuDirector
- Robert MitchellDirector
- Patrick van BenedenDirector
- Erik AmbleDirector
- Olivier LitzkaDirector
- Victoria Carr-BrendelExecutive Officer, Director
- Jan PensaertDirector
- Jan KeltjensDirector
- Peter WulffExecutive Officer
- Arnd KaltofenDirector
- Offering amount
- $9.4M
- Amount sold
- $9.4M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedAug 2016 · 11 investors · Other Health CareRule 506(b)
▶$10MraisedAug 2016 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jan PensaertDirector
- Raymond CohenDirector
- Peter WulffExecutive Officer
- Arnd KaltofenDirector
- Jan KeltjensDirector
- Patrick van BenedenDirector
- Ouyang XiangyuDirector
- Victoria Carr-BrendelExecutive Officer, Director
- Erik AmbleDirector
- Olivier LitzkaDirector
- Offering amount
- $23M
- Amount sold
- $10M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.5MraisedAug 2015 · 13 investors · Other Health CareRule 506(b)
▶$26.5MraisedAug 2015 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Arnd KaltofenDirector
- Raymond CohenDirector
- Erik AmbleDirector
- Jan KeltjensDirector
- Peter BarrettDirector
- Olivier LitzkaDirector
- Ouyang XiangyuDirector
- Patrick van BenedenDirector
- Victoria Carr-BrendelExecutive Officer, Director
- Hans-Reiner FigullaDirector
- Offering amount
- $26.5M
- Amount sold
- $26.5M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.